OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study
Adrián Viudez‐Martínez, Angela Pascual‐Carrasco, Isabel Beltrán‐Blasco, et al.
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 6, pp. 814-823
Open Access | Times Cited: 12

Showing 12 citing articles:

Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data
Antun R. Pavelić, Christian Wöber, Franz Riederer, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 38

Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis
Jaime Fernández-Bravo-Rodrigo, Iván Cavero‐Redondo, Maribel Lucerón‐Lucas‐Torres, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176702-176702
Closed Access | Times Cited: 3

First Report of Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE or Baboon Syndrome) After Erenumab Application for Migraine Prevention
Carl Göbel, Axel Heinze, Sarah Karstedt, et al.
Pain and Therapy (2022) Vol. 11, Iss. 4, pp. 1483-1491
Open Access | Times Cited: 9

Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5

Photophobia and migraine outcome during treatment with galcanezumab
Francesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 4

Real-world experience of galcanezumab in the prevention of migraine in Spain: a systematic literature review
Patricia Pozo‐Rosich, David García‐Azorín, Silvia Díaz‐Cerezo, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1

Effect of acupuncture combined with auricular beanembedding on autonomic nervous system function, heart rate variability and mental state of migraine patients
Yunqi Lu, Zhengda Sun, Peiyan Huang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 10, pp. 6148-6158
Closed Access

Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario
Andrea Zovi, Ruggero Lasala, Francesco Ferrara, et al.
Hospital Pharmacy (2023) Vol. 59, Iss. 2, pp. 165-172
Open Access

Erenumab/galcanezumab

Reactions Weekly (2022) Vol. 1916, Iss. 1, pp. 197-197
Closed Access

Page 1

Scroll to top